
The day after Novartis gained a new US licence for Lucentis to treat diabetic macular oedema, new data was published …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

